900
Participants
Start Date
May 31, 2006
Primary Completion Date
July 31, 2006
Study Completion Date
October 31, 2006
Influenza split vaccine of 15 μg HA
60 subjects were assigned (20 infants, 20 children and 20 adults) to receive influenza vaccine (split virion), inactivated, 0.5ml, one dose regime
Influenza split vaccine of 15 μg HA
558 subjects were assigned to receive influenza split vaccine, 0.5ml, one dose regime
Influenza split vaccine
280 subjects were assigned to receive influenza split vaccine, 0.5ml, one dose regime
Jiangsu Provincial Center for Disease Prevention and Control, Nanjing
Lead Sponsor
Hualan Biological Engineering, Inc.
INDUSTRY